highest dose of retatrutide Dosing Guide: 1-12 mg Weekly Triple Agonist (2026) Retatrutide Dosage Guide 2026: Phase

Jeyaraman M, Muthu S, Sharma S, Ganta C, Ranjan R, Jha SK

Claxton A, Baker LD, Hanson A, Trittschuh EH, Cholerton B, Morgan A, et al

The compound received FDA GRAS status for safety but was never approved as a drug because efficacy was insufficient for pharmaceutical registration

Each additional receptor target adds measurable metabolic effect

On Tuesday morning, the pharma giant announced that its oral GLP-1 drug orforglipron successfully met all the key primary and secondary endpoints set for the drug in a Phase 3 trial

GLP-1RAs have multifaceted biological functional properties, positioning them as a potential therapeutic option for DPN